Negara: Australia
Bahasa: Inggris
Sumber: Department of Health (Therapeutic Goods Administration)
Tapentadol hydrochloride
CSL Limited
Medicine Registered
1 PALEXIA ® SR SUSTAINED RELEASE TABLETS Tapentadol _(TA-PEN-TA-DOL)_ CONSUMER MEDICINE INFORMATION_ _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about PALEXIA ® SR. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you having PALEXIA ® SR against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR, NURSE OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT PALEXIA ® SR IS USED FOR PALEXIA ® (tapentadol) SR is used to relieve chronic, around the clock pain, that is moderate to severe pain and is expected to be long lasting. This strong pain reliever belongs to a group of medicines known as opioid analgesics. This medicine is available only with a doctor’s prescription. PALEXIA ® SR tablets are designed to release the pain reliever gradually over several hours. Your doctor may have prescribed PALEXIA ® SR for another reason. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY PALEXIA ® SR HAS BEEN PRESCRIBED FOR YOU. BEFORE YOU TAKE PALEXIA ® SR _WHEN YOU MUST NOT _ _TAKE IT _ YOU MUST NOT TAKE PALEXIA ® SR IF YOU: are allergic to tapentadol or any of the ingredients at the end listed at the end of this leaflet. Signs of allergic reaction may include a skin rash, itching, shortness of breath or swelling of the face, lips or tongue_ _ have asthma or if your breathing is dangerously slow or shallow (respiratory depression, hypercapnia) have pa Baca dokumen lengkapnya
1 PALEXIA ® SR PRODUCT INFORMATION AUST R 165332, 165346, 165347, 165356, 165357 NAME OF THE MEDICINE PALEXIA ® SR 50 mg (tapentadol as hydrochloride) sustained release tablets PALEXIA ® SR 100 mg (tapentadol as hydrochloride) sustained release tablets PALEXIA ® SR 150 mg (tapentadol as hydrochloride) sustained release tablets PALEXIA ® SR 200 mg (tapentadol as hydrochloride) sustained release tablets PALEXIA ® SR 250 mg (tapentadol as hydrochloride) sustained release tablets DESCRIPTION PALEXIA ® SR sustained release tablets contain tapentadol hydrochloride (HCl) which is a centrally acting synthetic analgesic combining mu agonist and noradrenaline re-uptake inhibition activity in a single molecule. Tapentadol is a white to off-white powder; freely soluble in water and methanol, and soluble in ethanol. The pKa 1 is 9.36 and pKa 2 is 10.37 determined in 0.15 M KCl solution. The partition coefficient is defined as the ratio of the equilibrium concentrations of a single neutral molecular species in a 1-octanol/aqueous buffered solution 2-phase system. The value of log P for tapentadol hydrochloride in 1-octanol/water is 2.89 ± 0.01. The chemical name for tapentadol HCl is 3-[(1_R_,2_R_)-3-(dimethylamino)-1-ethyl-2- methylpropyl]phenol monohydrochloride. The molecular weight of tapentadol HCl is 257.80, and the empirical formula is C 14 H 23 NO •HCl. The structural formula of tapentadol HCl (CAS number: 175591-09-0) is: . HCl N OH _(R)_ _(R)_ PALEXIA ® SR tablets contain 50, 100, 150, 200 and 250 mg tapentadol (as hydrochloride). Excipients are: hypromellose 100,000 mPa-s, microcrystalline cellulose, colloidal anhydrous silica and magnesium stearate. Excipients in the film coat are: hypromellose 6 mPa-s, lactose monohydrate, talc, Baca dokumen lengkapnya